SP0273 & SP0237——Sanofi流感疫苗管线

生物制品圈
14 May

导读:疫苗接种是防控传染病的关键手段,尤其对于控制新兴病原体的大流行至关重要。近年来,mRNA疫苗技术的突破为传统疫苗技术带来了更安全的选择。新冠肺炎疫苗的临床效果已经显现,同时,众多候选疫苗也在积极推进临床开发。Sanofi在mRNA流感疫苗的研发与生产领域持续倾注了大量精力与资源。2024年7月25日,Sanofi发布的第二季度财报中,流感疫苗作为公司的优势品种,二季度销售额达到了1.15亿...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10